ATE375798T1 - Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion - Google Patents

Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Info

Publication number
ATE375798T1
ATE375798T1 AT00904375T AT00904375T ATE375798T1 AT E375798 T1 ATE375798 T1 AT E375798T1 AT 00904375 T AT00904375 T AT 00904375T AT 00904375 T AT00904375 T AT 00904375T AT E375798 T1 ATE375798 T1 AT E375798T1
Authority
AT
Austria
Prior art keywords
sepsis
intravenous infusion
treatment
methods
endotoxemia
Prior art date
Application number
AT00904375T
Other languages
English (en)
Inventor
Daniel Rossignol
Melvyn Lynn
William Kerns
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Application granted granted Critical
Publication of ATE375798T1 publication Critical patent/ATE375798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00904375T 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion ATE375798T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11620299P 1999-01-14 1999-01-14

Publications (1)

Publication Number Publication Date
ATE375798T1 true ATE375798T1 (de) 2007-11-15

Family

ID=22365882

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07019438T ATE501760T1 (de) 1999-01-14 2000-01-14 E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen
AT00904375T ATE375798T1 (de) 1999-01-14 2000-01-14 Verwendung von e5564 zur behandlung von sepsis durch intravenöse infusion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07019438T ATE501760T1 (de) 1999-01-14 2000-01-14 E5564 zur verwendung in der behandlung von allograft-abstossung oder host-versus-graft- erkrankungen

Country Status (11)

Country Link
EP (3) EP2298326A3 (de)
JP (1) JP2002534471A (de)
AT (2) ATE501760T1 (de)
AU (1) AU2614400A (de)
CA (1) CA2359478A1 (de)
CY (1) CY1108039T1 (de)
DE (2) DE60045750D1 (de)
DK (1) DK1158990T3 (de)
ES (1) ES2291188T3 (de)
PT (1) PT1158990E (de)
WO (1) WO2000041703A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001093921A2 (en) * 2000-06-09 2001-12-13 Eisai Co., Ltd. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
AU2002323106A1 (en) * 2001-08-10 2003-02-24 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
EP3229813B1 (de) * 2014-12-12 2021-03-24 The Feinstein Institute for Medical Research Behandlung von hmgb1-vermittelten entzündungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia

Also Published As

Publication number Publication date
DE60036790T2 (de) 2008-07-24
EP2298326A2 (de) 2011-03-23
EP2298326A3 (de) 2011-04-27
ES2291188T3 (es) 2008-03-01
AU2614400A (en) 2000-08-01
EP1158990A4 (de) 2003-08-13
CA2359478A1 (en) 2000-07-20
EP1867336A3 (de) 2008-04-23
EP1158990B1 (de) 2007-10-17
ATE501760T1 (de) 2011-04-15
DE60045750D1 (de) 2011-04-28
EP1867336A2 (de) 2007-12-19
CY1108039T1 (el) 2013-09-04
WO2000041703A1 (en) 2000-07-20
JP2002534471A (ja) 2002-10-15
DE60036790D1 (de) 2007-11-29
PT1158990E (pt) 2007-12-21
DK1158990T3 (da) 2008-01-28
EP1867336B1 (de) 2011-03-16
EP1158990A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
ATE246197T1 (de) Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren
FR12C0004I1 (de)
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
HUP9700368A2 (hu) II-típusú diabetes mellitus kezelése amilin agonistákkal
ATE350385T1 (de) Neue aryl fructose-1,6-bisphosphatase inhibitoren
DE69725825D1 (de) 5-HT1F-Agonisten
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
CY1108039T1 (el) Χρηση e5564 για την θεραπεια σηψαιμιας με ενδοφλεβια εγχυση
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
ATE209914T1 (de) Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen
ATE517617T1 (de) Behandlung von parkinson erkrankung mit kape
EA199800821A1 (ru) Способ лечения аутизма
WO2001093921A3 (en) Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
DE60020729D1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ATE335504T1 (de) Humanisierte antikörper zur erkennung von verotoxin ii sowie zellinie zur herstellung derselben
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE60110468D1 (de) Chemische verbindungen
DE60233353D1 (de) Verfahren zur behandlung von halitose
SE9702993D0 (sv) Anti-mikrobial komposition
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
UA29106A (uk) Спосіб лікування вібраційної хвороби

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1158990

Country of ref document: EP